Skip to main content

Drugcen

LuciCapma 200mg (Capmatinib)

LuciCapma 200mg (capmatinib) by Lucius Pharmaceuticals is a MET inhibitor for MET exon 14 lung cancer. Prescription required.

Need the latest price or ready to buy? Tap the Order Now button on this page, share your prescription on chat, and our pharmacy team will reply with today’s price, stock availability and delivery details.

Order Now

+8801721910505

Description

LuciCapma 200mg is a prescription tablet containing capmatinib, a MET inhibitor used for metastatic non small cell lung cancer (NSCLC) with a MET exon 14 skipping mutation. It must be used under the supervision of a qualified doctor.

What Is LuciCapma 200mg Used For?

Capmatinib is used for metastatic non small cell lung cancer (NSCLC) with a MET exon 14 skipping mutation. The US FDA approved capmatinib (Tabrecta) for adults with metastatic NSCLC whose tumors have a MET exon 14 skipping mutation. Your doctor decides whether it is suitable for you.

How Does Capmatinib Work?

It blocks the MET receptor, which drives cancer growth when it is altered.

Strength and Dosage

LuciCapma 200mg contains 200 mg of capmatinib per tablet. The dose, schedule and length of treatment depend on your condition, your other medicines and your test results, and your doctor sets them. Never change or stop your dose without medical advice.

Other options with the same active ingredient on Drugcen: Capmaxen 200mg.

Common Side Effects

Side effects reported with capmatinib include swelling of the legs and hands, nausea, fatigue, vomiting, shortness of breath and reduced appetite. Contact your doctor early if any of these become severe or do not settle.

Important Safety Information

It can cause lung inflammation, liver problems and sun sensitivity, so lung symptoms and liver tests should be watched. Tell your doctor about all medicines and supplements you take, your health conditions, and any plan for pregnancy or breastfeeding before you start. Store in the original pack, away from heat, moisture and children.

Product Details

Product LuciCapma 200mg
Active ingredient Capmatinib 200 mg
Drug class MET inhibitor
Form Oral tablet
Manufacturer Lucius Pharmaceuticals
Pack size As stated on the pack
Prescription Required

Frequently Asked Questions

What is LuciCapma 200mg?

LuciCapma 200mg is a prescription tablet containing capmatinib, a MET inhibitor used for MET exon 14 lung cancer.

What is capmatinib used for?

Capmatinib is used for metastatic non small cell lung cancer (NSCLC) with a MET exon 14 skipping mutation.

Is a prescription needed for LuciCapma 200mg?

Yes. A valid prescription from a qualified doctor is required. Share it on chat through the Order Now button and our pharmacy team will guide you on the next steps.

What are the common side effects of capmatinib?

Common side effects include swelling of the legs and hands, nausea, fatigue, vomiting, shortness of breath and reduced appetite. Contact your doctor if any side effect becomes severe or does not settle.

How can I get the price of LuciCapma 200mg?

Tap the Order Now button on this page and send your prescription on chat. Our pharmacy team will reply with today’s price, stock availability and delivery details.

Questions about this product? Contact our pharmacy team or visit our online pharmacy for more medicines.

Reviews

There are no reviews yet.

Be the first to review “LuciCapma 200mg (Capmatinib)”

Your email address will not be published. Required fields are marked *